Cargando…
Outcomes of Multi-Drug Resistant Tuberculosis (MDR-TB) among a Cohort of South African Patients with High HIV Prevalence
BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) is a major clinical challenge, particularly in patients with human immunodeficiency virus (HIV) co-infection. MDR-TB treatment is increasingly available, but outcomes have not been well characterized. South Africa has provided MDR-TB treatment fo...
Autores principales: | Farley, Jason E., Ram, Malathi, Pan, William, Waldman, Stacie, Cassell, Gail H., Chaisson, Richard E., Weyer, Karin, Lancaster, Joey, Van der Walt, Martie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142109/ https://www.ncbi.nlm.nih.gov/pubmed/21799728 http://dx.doi.org/10.1371/journal.pone.0020436 |
Ejemplares similares
-
Development and Evaluation of a Pilot Nurse Case Management Model to Address Multidrug-Resistant Tuberculosis (MDR-TB) and HIV in South Africa
por: Farley, Jason E., et al.
Publicado: (2014) -
Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study
por: Finlay, Alyssa, et al.
Publicado: (2012) -
Tuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000-2008, South Africa
por: van der Walt, Martie, et al.
Publicado: (2016) -
‘Z(S)-MDR-TB' versus ‘Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility
por: Zhang, Ying, et al.
Publicado: (2012) -
Serious Treatment Related Adverse Drug Reactions amongst Anti-Retroviral Naïve MDR-TB Patients
por: Van der Walt, Martha, et al.
Publicado: (2013)